Nayak Sanjay's Form 4 filing
Ocular Therapeutix, Inc (OCUL) · filed Aug 26, 2026
- Accession no.
- 0001104659-26-101671
- Filed
- Aug 26, 2026, 5:58 PM ET
- Trade date
- Aug 24, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $20.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Nayak SanjayCIK 0002012715 | Officer (Chief Strategy Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 24, 2026 | Common Stock | SSaleDisposed | −1,897 | $10.78 | −$20,449.66 | 326,898 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.